Abstract
Aims and Objectives: To compare the diagnostic yield of CBNAAT method for BAL fluid and sputum for detection of mycobacterium to diagnose pulmonary tuberculosis.
Material and Methods: 129 sputum and BAL specimens from 129 patients were studied which included 65 specimens from sputum culture positive TB patients and 64 specimens from sputum culture negative patients. Patients with Sputum culture negative for MTB were considered as control.
Observation: It was observed that out of 65 culture positive cases of pulmonary tuberculosis, 43 were sputum CBNAAT (+)ve and 54 were CBNAAT (+)ve in BAL. Sensitivity and specificity of CBNAAT for sputum was 66.15% and 100% respectively. Sensitivity and specificity of CBNAAT for BAL was 83.07% and 100% respectively.
Conclusion: our study suggests that BAL-CBNAAT shows additional advantage of confirmatory diagnosis of the disease even if sputum CBNAAT is negative.
References
- WHO. October 2015. Archivedfrom the original on 23 August 2012. Retrieved 11 February 2016.
- "Global tuberculosis report". World Health Organization. Retrieved 2017-11-09.
- “End TB Strategy” https://www.who.int/tb/strategy/end-tb/en/
- https://www.who.int/news-room/fact-sheets/detail/tuberculosis 18th September 2018.
- World Health Organization: WHO report 2010: global tuberculosis control. Geneva, Switzerland: WHO; 2010.
- Rachow A, Zumla A, Heinrich N et al. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay - a clinical validation study. PLoS One 2011; 6: e20458.
- Centers for Disease Control and Prevention (CDC). Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep. 2009;58:7-10.
- Kwon YS, Koh WJ. Diagnosis of pulmonary tuberculosis and nontuberculous mycobacterial lung disease in Korea. Tuberc Respir Dis. 2014;77:1-5.
- Avashia S, Choubey S, Mishra S, kharate A. To study the usefulness of CBNAAT (cartridge based nuclear acid amplification test) in BAL (bronchoalveolar lavage) samples in the diagnosis of smear-negative/non sputum producing patients with suspected tuberculosis. J Evolution Med Dent Sci. 2016;5(1):55-59.
- Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, et al. Cochrane Library 2013 http://doi.wiley.com/10.1002/14651858.CD009593.pub2
- Ioannidis P, Papaventsis D, Karabela S, Nikolaou S, Panagi M, Raftopoulou E, et al. Cepheid GeneXpert MTB/RIF assay for mycobacterium tuberculosis detection and rifampin resistance identification in patients with substantial clinical indications of tuberculosis and smear-negative microscopy results. Journal of Clinical Microbiology. 2011;49(8):3068-70.
Corresponding Author
Dr Gajendra Vikram Singh
Md, Associate Proff., Deptt. of Tuberculosis and Respiratory Diseases, S.N. Medical College, Agra, (UP) India
DOI: https://dx.doi.org/10.18535/jmscr/v7i7.25
